3.0.0 3942 2023-01-11T13:46:15Z 2023-01-11T13:46:15Z Senate S 2020-06-11 116 ssfi00 Finance Committee Senate Standing Referred to 2020-06-11T17:23:36Z Lower Costs, More Cures Act of 2019 116 19 HR 2019-12-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Related bill CRS Fixing Global Freeloading Act 116 2209 HR 2019-04-10 Referred to the Subcommittee on Trade. Related bill CRS Competition Prescription Act of 2019 116 3947 HR 2019-08-28 Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties. Related bill CRS Lower Costs, More Cures Act of 2019 116 3129 S 2019-12-19 Read twice and referred to the Committee on Finance. Related bill CRS 2020-06-11 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2020-06-11 Introduced in Senate IntroReferral 10000 9 Library of Congress L000594 Sen. Loeffler, Kelly [R-GA] Kelly Loeffler R GA N Foreign Trade and International Finance Competitiveness, trade promotion, trade deficits Congressional oversight Executive agency funding and structure Federal officials Government employee pay, benefits, personnel management Health technology, devices, supplies Office of the U.S. Trade Representative Prescription drugs Trade agreements and negotiations Foreign Trade and International Finance 00 2020-06-11 Introduced in Senate 2020-12-30T21:24:08Z Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act

This bill establishes the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the U.S. Trade Representative. The negotiator must conduct trade negotiations and enforce trade agreements related to pharmaceutical products and services and medical supply chains.

]]> Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act Display Title Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act Short Title(s) as Introduced Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act Introduced in Senate IS Official Title as Introduced A bill to establish the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the United States Trade Representative, to be responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward United States innovation with respect to pharmaceuticals, to advance domestic production of life-saving medicines, and to secure the United States medical supply chain to eliminate reliance on foreign governments, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-06-11T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s3942is/xml/BILLS-116s3942is.xml 2020-06-11 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.